Glycomimetics(GLYC)

超过5%股东持股披露「修订」

Glycomimetics(GLYC)03-01 08:35

$Glycomimetics(GLYC)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001072613-24-000287  Act: 34  Size: 350 KB 网页链接查看全文

其他

Glycomimetics(GLYC)03-23 05:05

$Glycomimetics(GLYC)$ PRE 14A Other preliminary proxy statements Accession Number: 0001558370-24-003788  Act: 34  Size: 1 MB 网页链接查看全文

员工持股计划

Glycomimetics(GLYC)03-28 04:05

$Glycomimetics(GLYC)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001558370-24-004078  Act: 33  Size: 178 KB 网页链接查看全文

美股滚雪球03-27 22:01

$Glycomimetics(GLYC)$ 在二季度发布 Topline data from pivotal Phase 3 study of Uproleselan in relapsed/refractory (R/R) AML，对股价影响很大。$传奇生物(LEGN)$ $美团-W(03690)$查看全文

超过5%股东持股披露「修订」

Glycomimetics(GLYC)02-13 05:55

$Glycomimetics(GLYC)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001072613-24-000125  Act: 34  Size: 346 KB 网页链接查看全文

超过5%股东持股披露「修订」

Glycomimetics(GLYC)01-30 05:35

$Glycomimetics(GLYC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-24-000153  Act: 34  Size: 277 KB 网页链接查看全文

股东委托书协议

Glycomimetics(GLYC)04-01 20:35

$Glycomimetics(GLYC)$ DEF 14A Other definitive proxy statements Accession Number: 0001558370-24-004448  Act: 34  Size: 1 MB 网页链接查看全文

当期报告

Glycomimetics(GLYC)03-01 22:25

$Glycomimetics(GLYC)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001558370-24-002241  Act: 34  Size: 7 MB 网页链接查看全文

年度财报

Glycomimetics(GLYC)03-27 20:35

$Glycomimetics(GLYC)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-004013  Act: 34  Size: 7 MB 网页链接查看全文

其他

Glycomimetics(GLYC)04-01 20:35

$Glycomimetics(GLYC)$ ARS Annual Report to Security Holders Accession Number: 0001558370-24-004451  Act: 34  Size: 4 MB 网页链接查看全文

叶枫价值2020-12-17 20:33

$Glycomimetics(GLYC)$成交量太小了，为啥如此惜售？查看全文

有为的股价小宝石2020-12-14 23:50

$Glycomimetics(GLYC)$ 先小仓买点，希望跌下来进大仓[跪了]查看全文

叶枫价值2020-12-07 23:26

$Glycomimetics(GLYC)$资金在流出，有人拉高出货吗？查看全文

有为的股价小宝石2020-12-06 10:33

$Glycomimetics(GLYC)$ AML动物实验数据不错，希望下周起飞[跪了]查看全文

冷枪手假亦真2020-12-02 05:29

$Glycomimetics(GLYC)$ 预感会飞的节奏～查看全文

有为的股价小宝石2020-12-01 23:42

$Glycomimetics(GLYC)$ 上车查看全文

美股马甲2020-11-17 23:55

$Glycomimetics(GLYC)$ @亚军联赛 你挑的GLYC很不错，在AML上挺有希望。
Rivipansel在SCD上失败了，这个几乎不用看了。
Uproleselan R/R AML 得明年完成试验病人入组。
根据PhI的数据，R/R AML CR/CRi 41%， mOS 8.8 vs 5.4 (historic)， MRD- 70% (n=16)
Newly diagnosed fit AML...查看全文

冷枪手假亦真2020-11-12 01:34

$Glycomimetics(GLYC)$ 买点试试查看全文

Kate7311172020-10-06 20:38

$Glycomimetics(GLYC)$ 最近真是神了，全是坏消息，好消息的也不涨查看全文

chuminhua2020-02-12 16:33

2/11, 2011年Pfizer$辉瑞(PFE)$ 与GlycoMimetics$Glycomimetics(GLYC)$ 达成授权许可协议，共同开发炎症抑制剂GMI-1070（Rivipansel）用于镰状细胞病治疗，交易价值3.4亿美元。但是现在，GlycoMimetics在SEC上发布文件称，2月5日该公司收到了Pfizer终止协议的书面通知，将在4月5日生效。协议终止后...查看全文

持股变动声明

$Glycomimetics(GLYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009744  Size: 5 KB 网页链接

持股变动声明

$Glycomimetics(GLYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009743  Size: 7 KB 网页链接

持股变动声明

$Glycomimetics(GLYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009745  Size: 4 KB 网页链接

股东委托书协议

$Glycomimetics(GLYC)$ DEF 14A Other definitive proxy statements Accession Number: 0001558370-24-004448  Act: 34  Size: 1 MB 网页链接

其他

$Glycomimetics(GLYC)$ ARS Annual Report to Security Holders Accession Number: 0001558370-24-004451  Act: 34  Size: 4 MB 网页链接

员工持股计划

$Glycomimetics(GLYC)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001558370-24-004078  Act: 33  Size: 178 KB 网页链接

当期报告

$Glycomimetics(GLYC)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-24-004015  Act: 34  Size: 427 KB 网页链接

年度财报

$Glycomimetics(GLYC)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-004013  Act: 34  Size: 7 MB 网页链接

其他

$Glycomimetics(GLYC)$ PRE 14A Other preliminary proxy statements Accession Number: 0001558370-24-003788  Act: 34  Size: 1 MB 网页链接

当期报告

$Glycomimetics(GLYC)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001558370-24-002241  Act: 34  Size: 7 MB 网页链接